RxDoctor Payments Data

Jana Stovall, NP

Family · Lynchburg, TNNPI 1811317068

Payments from drug & device makers

$468in general payments, 2019–2025

Across 24 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$325
  • Hikma Pharmaceuticals USA$62
  • Exact Sciences$19
  • Idorsia Pharmaceuticals US Inc$17
  • Lilly USA, LLC$16
  • Virtus Pharmaceuticals LLC$15
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$44796%
  • Education$214%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$468 in reported general payments places this provider in the 50th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$46,271
Medicare patients
155
Services billed
583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl170$162,677
Xtampza ErOxycodone Myristate135$136,801
PercocetOxycodone Hcl/Acetaminophen12$63,259
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,703$45,968
Oxycodone Hcl1,974$45,693
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,468$36,275
Oxymorphone Hcl ErOxymorphone Hcl25$26,622
Morphine Sulfate ErMorphine Sulfate1,023$24,666
Gabapentin1,705$22,075
LinzessLinaclotide36$18,473
Fentanyl68$13,780
Hysingla ErHydrocodone Bitartrate26$13,006
Tizanidine Hcl686$11,429
Pregabalin623$9,512
BelbucaBuprenorphine Hcl12$9,221

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$325$146,023147 claims
Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Morphine Sulfate$62$11,33398 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,706 family providers in Tennessee.

Other family in Lynchburg

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →